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Abstract
Enterotoxigenic Escherichia coli (ETEC) is an important cause of acute watery diarrhoea in developing countries.
Colonization factors (CFs) on the bacterial surface mediate adhesion to the small intestinal epithelium. Two of the most
common CFs worldwide are coli surface antigens 5 and 6 (CS5, CS6). In this study we investigated the expression of CS5 and
CS6 in vivo, and the effects of bile and sodium bicarbonate, present in the human gut, on the expression of CS5. Five
CS5+CS6 ETEC isolates from adult Bangladeshi patients with acute diarrhoea were studied. The level of transcription from
the CS5 operon was approximately 100-fold higher than from the CS6 operon in ETEC bacteria recovered directly from
diarrhoeal stool without sub-culturing (in vivo). The glyco-conjugated primary bile salt sodium glycocholate hydrate
(NaGCH) induced phenotypic expression of CS5 in a dose-dependent manner and caused a 100-fold up-regulation of CS5
mRNA levels; this is the first description of NaGCH as an enteropathogenic virulence inducer. The relative transcription levels
from the CS5 and CS6 operons in the presence of bile or NaGCH in vitro were similar to those in vivo. Another bile salt,
sodium deoxycholate (NaDC), previously reported to induce enteropathogenic virulence, also induced expression of CS5,
whereas sodium bicarbonate did not.
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Introduction
Enterotoxigenic E. coli (ETEC) is one of the most common
causes of acute watery diarrhoea in the developing world, both
among children and adults, causing up to 400 million diarrhoeal
episodes and approximately 380.000 deaths in children under the
age of five every year. In addition, ETEC causes approximately
400 million diarrhoeal cases among adults. ETEC is also the most
common cause of travellers diarrhoea in these countries [1–5].
ETEC is endemic in many countries such as Bangladesh where the
infection follows a distinct biannual seasonal pattern with one peak
during the hot and dry months of April and May, and a second
peak in September and October when the heavy monsoon rains
have subsided [6].
ETEC infection is acquired by ingestion of contaminated food
or water, and the infection is established when the bacteria reach
the small intestine. Diarrhoea is caused by the actions of one or
two enterotoxins, the heat-stable (ST) and/or the heat-labile (LT)
toxin, which bind to receptors on the epithelial surface, thereby
activating signalling pathways that stimulate the opening of ion
channels [2,5,7] and subsequent release of water and electrolytes
into the intestinal lumen. Colonization of the small intestine is
mediated by colonization factors (CFs), which are fimbrial, fibrillar
or afimbrial structures on the bacterial surface that adhere to the
enterocytes. At present at least 25 different CFs have been
identified [8–11]. Two of the most common CFs expressed by
clinical isolates from different parts of the world are the coli surface
antigens 5 (CS5) and 6 (CS6) [5,9,12–14]. CS5 and CS6 belong to
the colonization factor antigen group IV (CFA/IV) which also
contains coli surface antigen 4 (CS4). CS5 is always expressed
together with CS6, while CS6 can also be expressed alone or
together with CS4 [9,15]. CS5 is a fibrillar antigen, and its operon
encodes a major subunit (csfA), a minor subunit (csfD), an outer
membrane usher (csfC), two chaperones (csfB and csfF), and a
protein involved in pilus length regulation (csfE) [16]. CS6 is
afimbrial and is composed of two structural subunits, CssA and
CssB, located on the bacterial cell membrane. The CS6 operon
contains four genes, cssA, cssB, cssC, and cssD, encoding the two
structural subunits CssA and CssB, a chaperone (CssC), and an
usher (CssD), respectively [17]. The current knowledge about the
regulation of CS5 and CS6 is limited, and the present study was
conducted in order to increase the understanding of the regulation
of these important virulence factors in the human gut, with an
emphasis on CS5.
When bacteria enter and colonize the gastrointestinal tract they
encounter a variety of host environmental factors that may
influence virulence gene expression, e.g. bile and sodium
bicarbonate, which have previously been shown to regulate
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NaHCO3 is secreted from the pancreas into the duodenum, and is
also released from the CFTR channels which results in an increase
in pH. Bile has detergenic properties and acts as an emulsifier of
dietary fats and lipids in vivo [22] and plays a role in antimicrobial
defence [23]. It is produced by the liver and contains many
components including bile acids, cholesterol, phospholipids, and
biliverdin [23]. Primary bile acids are produced directly from
cholesterol in the liver by the hepatocytes, and secondary bile acids
are produced by bacteria in the caecum and colon by
modifications of the primary bile acids. Primary and secondary
bile acids are modified by the hepatocytes by conjugation with
either glycine (glyco-conjugated bile acids) or taurine (tauro-
conjugated bile acids) [22,23]. Bile salts are secreted into the
duodenum at estimated concentrations of 0.2–2% [24].
In this study we investigated the expression of CS5 and CS6 in
ETEC bacteria isolated without sub-culturing from clinical stool
samples (in vivo). The effects of sodium bicarbonate and bile on the
expression of CS5 were investigated in in vitro cultured bacteria. A
certain component of bile, sodium glycocholate hydrate, was
identified as a potent inducer of CS5 expression. To our
knowledge this is the first report that implicates this molecule as
an inducer of enteropathogenic bacterial virulence.
Results
CS5+CS6, LT+ST ETEC Strains Isolated from Bangladeshi
Stool Specimens
Four clinical ETEC strains from stool specimens collected in
2005 and 2006 from adult patients with acute diarrhoea at the
icddr,b hospital in Dhaka were included in the study (Table 1). An
LT+STh, CS5+CS6 laboratory reference strain (E3003; some-
times referred to as VM 75689 in other studies), originally isolated
in Dhaka in 1988, was also included. A total of 127 clinical stool
specimens were collected in 2005 between April and June during
the ETEC peak season. Out of a total of 34 identified ETEC
positive stool specimens, five contained a CS5+CS6 positive strain
that expressed both the ST and the LT toxin. Strains E1777,
E1779, and E1785 were chosen for subsequent studies. A co-
infecting pathogen was only detected for the patient infected with
strain E1779, who had a co-infection with V. cholerae Ogawa.
Immune Responses Against the CS5 and CS6 ETEC
Strains
ELISA analyses of serum samples from the three patients from
whom the CS5+CS6 positive strains E1777, E1779, and E1785
had been isolated showed that on day 7 (early convalescence) the
patients infected with E1777 and E1785 had developed strong IgG
as well as IgA immune responses against CS5, whereas the patient
infected with strain E1779, who had a co-infection with V. cholerae
Ogawa, had developed only a very modest immune response (IgA
and IgG) against CS5 (Fig. 1). The patient infected with strain
E1785 also developed a strong immune response (IgA and IgG)
against CS6, whereas those infected with strains E1777 and E1779
exhibited modest immune responses (Fig 1). These results confirm
that CS5 and CS6 were indeed expressed and exposed on the
bacteria during the infection. The IgA responses induced against
CS6 were comparable to those previously reported for Banglade-
shi adults infected with CS5+CS6 ETEC strains [25].
Transcription of the CS5 and CS6 Operons in vivo
The transcription levels of the CS5 and CS6 operons in in vivo
bacterial samples was analyzed by extracting total RNA directly
from diarrhoeal stool bacteria and measuring the transcription
levels of the structural genes csfD and cssB of CS5 and CS6,
respectively, by quantitative real time reverse transcriptase PCR (rt
RT-PCR). Since the E. coli bacterial load in the diarrhoeal stool
specimens was unknown, and since there are no reliable E. coli
housekeeping genes for relative quantification, the relative ratio of
the transcription levels of csfD and cssB was determined and
compared instead of analyzing the transcription level of each
individual gene in relation to a housekeeping gene or a fixed
amount of RNA (Fig. 2). Transcription of the E. coli housekeeping
gene gapA was detected in all samples, concluding that intact E. coli
mRNA was present in all in vivo bacterial samples. Transcription of
csfD and cssB was observed in the three in vivo bacterial samples in
which ETEC was the only detected bacterial pathogen, i.e. those
containing strains E1777, E1785 and E2265 (Table 1). The sample
that contained V. cholerae in addition to ETEC, i.e. strain E1779,
was negative for transcription of both csfD and cssB; since
transcription of gapA was present, this was not due to the
deterioration of RNA but indicative of low levels of ETEC
bacteria in this particular stool sample.
Bile, but not Sodium Bicarbonate, Induces Phenotypic
Expression of CS5 both under Nutrient-rich and Nutrient-
poor Conditions
In order to investigate whether the expression of CS5 by ETEC
bacteria in vivo may be regulated by the host environmental factors
bile and NaHCO3, which are both abundant in the human
intestine, the strains were analyzed by an inhibition ELISA after in
vitro culture in the presence and absence of these factors. After
overnight culture to stationary phase in LB medium (all five
strains) as well as in M9 minimal medium supplemented with
glucose, glycerol, or casamino acids as the primary carbon source
(strains E1779 and E2265), CS5 was only detected on the bacterial
surface when bile was present in the culture medium. Crude bile is
routinely added to the culture medium (CFA medium) under
standard diagnostic laboratory conditions in order to enable
detection of phenotypic CS5, e.g. by dot-blot analysis [26]. Our
results indicate that the presence of bile is required for phenotypic
CS5 expression not only under nutrient-rich conditions, but also
under nutrient-poor conditions. NaHCO3 was tested at concen-
trations 0.3% (35.7 mM) and 0.6% (71.4 mM), which fall within
the concentration range previously reported to positively regulate
Table 1. Strains used in the study and results from culturing
a
of clinical stool specimens.
ETEC
strain
b:
Culture on
MacConkey
agar
c
Culture on
TTGA agar
CF and toxin
profile
of isolated ETEC
strain
Year of
isolation
in Dhaka
E1777 E. coli negative CS5+CS6, STh+LT April 2005
E1779 E. coli V.cholerae Ogawa CS5+CS6, STh+LT May 2005
E1785 E. coli negative CS5+CS6, STh+LT June 2005
E2265 E. coli negative CS5+CS6, STh+LT March 2006
E3003
c E. coli N.T. CS5+CS6, STh+LT 1988
aCulture was performed on MacConkey agar plates to detect E. coli and on
Taurocholate-tellurite-gelatin agar (TTGA) for detection of vibrios; all cultures
were performed overnight at 37uC.
bDepartment of Microbiology and Immunology, University of Gothenburg,
enterotoxigenic Escherichia coli (ETEC) strain collection number.
doi:10.1371/journal.pone.0035827.t001
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bacteria, i.e. Vibrio cholerae and enterohemorrhagic E. coli (EHEC)
[19,20]. However, overnight culture to stationary phase in LB
medium supplemented with NaHCO3 did not result in phenotypic
expression of CS5 in any of the five strains included in the study,
indicating that this host factor is not an inducer of CS5 expression.
Sodium Glycocholate Hydrate Induces Phenotypic
Expression of CS5
TheinductionofCS5expressionbycrudebilewasfoundnottobe
due to non-specific induction by the detergenic properties of bile,
sinceovernightculturetostationaryphaseinLBsupplementedwith
Triton X-100 (0.1% and 0.04%) did not result in phenotypic CS5
expression in any of the five strains included in the study.
Approximately 50% of the organic compounds in bile are
constituted by bile acids [23]. To individually investigate the effects
of some of the major bile salts in human bile on CS5 expression,
strain E1777 was cultured to stationary phase in LB supplemented
with the primary bile salts, i.e. sodium cholate hydrate (NaCH) and
sodium chenodeoxycholate (NaCDC) [23], respectively; the glyco-
and tauro-conjugated salts of NaCH, i.e. sodium glycocholate
hydrate (NaGCH) and taurocholic acid sodium salt hydrate (TCA),
respectively; and the secondary bile salt sodium deoxycholate
(NaDC), which is derived from cholic acid by dehydroxylation [23].
Theindividualbilesaltsweretestedatfinalconcentrationsof0.04%
and 0.2% (NaCH), 0.04%, 0.1% and 0.2% (NaDC), 0.04%, 0.1%
and 0.2% (TCA), 0.04% (NaCDC), and 0.04%, 0.1% and 0.2%
(NaGCH). Expression of CS5 on the bacterial surface was induced
by NaDC (results not shown), which is knownto induce virulence in
other enteropathogenic bacteria [21,27–30], as well as by the
glycoconjugate NaGCH. The tauro-conjugated counterpart of
NaGCH, TCA, and the corresponding unconjugated bile salt
NaCH, did not induce phenotypic CS5 expression, irrespectively of
the concentration used. The ability of NaGCH and the inability of
NaCH and TCA to induce CS5 surface expression was confirmed
for the clinical strains E1779, E1785, and E2265 as well as the
reference strain E3003, using a concentration of 0.2% of each
individual salt (Fig. 3).
Figure 1. IgA and IgG serum antibody responses to CS5 and CS6 in individual patients. The responses to CS5 (broken lines) and CS6 (solid
lines) were measured by ELISA in sera from patients infected with strains E1777, E1785 and E1779, on different days after hospitalization. Serum from
the patient infected with strain E2265 was not available.
doi:10.1371/journal.pone.0035827.g001
Figure 2. Transcriptional csfD:ccsB ratio in vivo and in vitro. Transcription of csfD and cssB was quantified by real time reverse transcriptase PCR
(rt RT-PCR) in in vivo bacterial samples (strains E1777, E1785, E2265; closed bar) and after one (strains E1785, E2265, E3003; open bars) and two (E1777,
E1779; hatched bars) hours of in vitro culture in LB medium alone and in LB supplemented with 0.15% crude bile or 0.2% individual bile salts. Bars
show the means and standard errors of the means of two (after two hours of culture) or three (in vivo and after one hour of culture) separate
experiments.
doi:10.1371/journal.pone.0035827.g002
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in vitro
The novel discovery that NaGCH may act as an inducer of
virulence was further investigated by studying the effects on
transcription of the CS5 operon by NaGCH, TCA, and NaCH.
As comparison, the effects of crude bile were also investigated.
This was performed by quantification of the transcription of csfD,
which encodes the CS5 minor structural subunit, in strains
cultured to exponential growth phase in LB medium alone and in
LB medium supplemented with 0.15% crude bile or 0.2%
NaGCH, 0.2% NaCH or 0.2% TCA, respectively. The
transcription of csfD was up-regulated approximately 100-fold
after one hour of culture when LB was supplemented with 0.15%
crude bile or 0.2% NaGCH as compared to after culture in LB
alone (Fig. 4). The up-regulation of csfD transcription was
significantly higher in LB medium supplemented with 0.15%
crude bile or 0.2% NaGCH, respectively, than in LB medium
supplemented with 0.2% NaCH or 0.2% TCA after one (Fig. 4),
two and five hours of culture (data not shown). Transcription of
the CS6 structural subunit gene cssB was up-regulated approxi-
mately 10-fold after the first hour of culture in LB medium
supplemented with 0.15% crude bile or 0.2% NaGCH as
compared to in LB medium alone (Fig. 4), and less than 10-fold
up-regulated or even down-regulated after two and five hours of
culture (not shown), indicating that the up-regulation of csfD in the
presence of bile or NaGCH was specific for the CS5 operon and
was not due to a general up-regulation of transcription.
The Induction of CS5 Expression by NaGCH is Dose-
dependent
Inhibition ELISA analyses of strain E1777 after overnight
culture to stationary phase in LB supplemented with NaGCH to a
final concentration of 0.4%, 0.2%, and 0.1%, respectively,
revealed that the induction of phenotypic CS5 expression by
NaGCH is dose-dependent (Fig. 5). Phenotypic expression of CS5
was also detected when a NaGCH concentration of 0.04% was
tested, but a NaGCH concentration of 0.004% was not sufficient
Figure 3. Phenotypic CS5 levels in LB alone and LB supple-
mented with bile or individual bile salts. CS5 expression was
quantified by inhibition ELISA after overnight culture to stationary
phase of strains E1777, E1779, E1785, E2265, and E3003. CS5 surface
expression tifwas induced by NaGCH, but not by the corresponding
unconjugated bile salt NaCH or its tauro-conjugated counterpart TCA
(representative data).
doi:10.1371/journal.pone.0035827.g003
Figure 4. Levels of csfD and cssB transcription compared to in LB alone after one hour of culture. Level of csfD (A) and cssB (B)
transcription in LB supplemented with crude bile or individual bile salts standardized to the level of transcription in LB medium alone, after one hour
of culture. Transcription was measured by reverse transcriptase real time PCR. Bars show means and standard errors of the means of three separate
experiments (strains E1785, E2265, and E3003, respectively). *, P=,0.05
doi:10.1371/journal.pone.0035827.g004
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induction of CS5 expression by crude bile is shown as comparison
in Fig. 5.
The Ratio Between csfD and cssB Transcription Levels is
Highest in vivo and in the Presence of Bile or NaGCH
in vitro
In vivo, i.e. in bacteria obtained directly from the stool
specimens without sub-culturing, the level of transcription of csfD
was higher than cssB. The transcriptional ratios of csfD to cssB
(csfD:cssB) were found to be 182:1, 65:1, and 76:1 for the samples
containing strains E1777, E1785, and E2265, respectively.
Similar csfD:cssB ratios were observed in vitro after one and two
hours of culture in LB medium supplemented with 0.15% crude
bile or 0.2% NaGCH (Fig. 2). On the other hand, culture in LB
medium alone or supplemented with 0.2% TCA or 0.2% NaCH
did not result in a similar ratio between csfD and cssB
transcription. Furthermore, the relative levels of transcription of
csfD and cssB in the presence of NaGCH was found to be dose-
dependent, as determined for strain E1777; the obtained csfD:cssB
ratios were 2:1 after overnight culture to stationary phase in LB
supplemented with 0.004% NaGCH, 75:1 in 0.04% NaGCH,
151:1 in 0.1%, 163:1 in 0.2%, and 207:1 in 0.4% NaGCH,
which supports that NaGCH is a specific inducer of transcription
of the CS5 operon.
Discussion
Diarrhoea caused by ETEC seems to require colonization of the
human intestine by different colonization factors. In this study we
have investigated the expression of the important ETEC
colonization factors CS5 and CS6 in vivo, as well as the role of
certain host factors in the human gastrointestinal tract as putative
regulators of CS5. These analyses have shown that expression of
CS5 is strongly enhanced in vivo as compared to CS6 and that a
specific factor in the human intestine, i.e. the glyco-conjugated
primary bile salt sodium glycocholate (NaGCH) can act as a
positive regulator of CS5 expression. To our knowledge, this is the
first description of induction of virulence by this bile component.
Relatively little has previously been known about the regulation
of CS5, especially in vivo. Under standard laboratory conditions
(overnight culture on CFA medium at 37uC), crude bile is
routinely added to the culture medium in order to enable
phenotypic expression of CS5 [26]. Our results show that bile
induces expression of CS5 not only in nutrient-rich media, but also
under nutrient-poor conditions where only amino acids, glycerol,
or glucose constitute the carbon source. In this study we wanted to
further investigate the dependency on bile for phenotypic CS5
expression to occur, and to elucidate how this induction comes
about. The induction was first determined not to be due to non-
specific effects of the detergent properties of bile, since addition of
a detergent (Triton X-100) to the culture medium failed to induce
phenotypic CS5 expression. Since bile salts form a major
constituent of human bile [23], we next decided to test some of
the major bile salts in human bile for effects on CS5 expression. A
number of enteric bacterial pathogens have previously been
reported to switch on the expression of virulence factors in the
presence of bile salts. For instance, in atypical enteropathogenic
Escherichia coli (aEPEC), phenotypic expression of the major
subunit of the afimbrial LDA adhesin has been reported to be
enhanced by a mixture of sodium deoxycholate, sodium
taurodeoxycholate, and sodium chenodeoxycholate [30]. In
Campylobacter jejuni, sodium deoxycholate, sodium cholate and
sodium chenodeoxycholate stimulate the production of Campylo-
bacter invasion antigens (Cia), thus affecting the invasiveness of the
bacteria [29], and in V. cholerae sodium cholate, sodium
deoxycholate and sodium taurocholate have been found to induce
phenotypic expression of the cholera toxin under certain in vitro
conditions [21]. In the case of ETEC, individual bile salts have not
previously been investigated for their effects on the expression of
the colonization factors. In this study we show that one of the bile
salts previously known to induce the expression of virulence factors
in Campylobacter, Shigella, Salmonella, and V. cholerae, sodium
deoxycholate (NaDC), also induces the expression of CS5. More
importantly, we were able to identify another positive regulator of
the common CS5, the glyco-conjugated primary bile acid sodium
glycocholate (NaGCH, or glycocholic acid in its acid form). To the
best of our knowledge this is the first study to report that this bile
acid can serve as an inducer of bacterial virulence. The crude bile
extract (Oxoid) that is routinely used for diagnostic purposes for
detection of CS5 is mainly composed of NaGCH and the sodium
salt of the tauro-conjugated counterpart of NaGCH, sodium
taurocholate (TCA), the latter of which we found is not able to
induce expression of CS5. Since glycocholic and taurocholic acid
have also been reported to be the main constituents of bile [31],
one may speculate that NaGCH is more important for CS5-
mediated virulence than NaDC in vivo. Glycocholate is formed by
the linking of a glycine amino group by an amide bond to the
carboxyl group of the primary bile acid cholic acid [23].
Considering that sodium cholate (NaCH) and TCA did not
induce expression of CS5, this indicates that the glycine amino
group in NaGCH is somehow a prerequisite for NaGCH to
positively regulate virulence gene expression. Studies to further
elucidate the role of the glycine group have been initiated, as well
as to determine the molecular basis of the positive regulation of
CS5 expression by NaGCH.
The induction of CS5 on the bacterial surface by NaGCH
was coupled with a dose-dependent up-regulation of the ratio
Figure 5. Dose-dependent induction of phenotypic CS5
expression by NaGCH. Expression of CS5 was determined by
inhibition ELISA in strain E1777 after overnight culture to stationary
phase in LB medium supplemented with NaGCH or crude bile. Bars
indicate means and standard errors of the means of two measurements
in one experiment.
doi:10.1371/journal.pone.0035827.g005
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regulation of CS5 expression at least partly occurs on the
transcriptional level. Interestingly, NaGCH has previously been
reported to activate certain promoters involved in E. coli stress
responses [32]. While the CS5 operon itself does not encode a
specific regulatory protein, the AraC/XylS-like transcription
factor CsvR has been suggested to positively regulate CS5
transcription [33,34]. These, and other possible pathways of
regulation of CS5 expression by NaGCH, are being explored
further. In contrast to CS5, no positive regulator has yet been
demonstrated for CS6 [35]. The transcription of the CS6
operon was not up-regulated to the same extent by NaGCH as
the transcription of the CS5 operon, suggesting that these two
operons are under the control of different regulators.
In the in vivo bacterial samples (collected from diarrhoeal stool
without sub-culturing), we found that the CS5 operon was
transcribed at approximately 100-fold higher levels than the
CS6 operon. Interestingly, these levels were similar to the levels
of up-regulation which were observed in vitro after one and two
hours of culture, when crude bile or NaGCH was added to the
culture media. Taken together, these results suggest that the
conditions encountered by ETEC bacteria in diarrhoeal stool
are mimicked by the conditions prevailing after one hour of
culture in LB medium supplemented by 0.2% NaGCH or
0.15% bile, at least when it comes to transcription of the CS5
and CS6 operons.
Transcription of csfD and cssB was detected in three of the four
patients included in the study; the exception was a patient who had
a co-infection with V. cholerae. This patient also exhibited a very
modest immune response to CS5 and CS6. Hence, it is tempting
to speculate about whether possible interactions between ETEC
and a co-infecting enteropathogen such as V. cholerae may result in
reduced expression of ETEC virulence genes, e.g. CS5. However,
further studies are needed to explore this.
In the in vivo setting, bile salts are secreted into the duodenum at
estimated concentrations of 0.2–2% [24]. In this study most
individual bile salts were tested at a concentration of 0.2%, since a
concentration of 0.15% crude bile is sufficient to induce expression
of CS5. However, the concentration of individual bile salts in vivo is
affected by the nutritional status of the host, e.g. the ingestion of a
fatty meal will increase their concentration, and the concentration
of bile in the intestinal lumen is lower in malnourished patients
[23]. The ratio of glyco-conjugated (e.g. NaGCH) to tauro-
conjugated (e.g. TCA) bile acids has also been reported to vary. It
has been reported to be 3:1 in the normal case, but to be much
lower (0.1:1) in taurine-fed individuals. Foods that are rich in
taurine include meat and sea-food, which will increase taurocon-
jugation [23]. In the light of our findings, this suggests that the diet
of an individual may influence the outcome of an infection with
CS5 positive ETEC, since certain diets may decrease the ratio
between glyco- and tauro-conjugates. One may speculate whether
a diet lacking adequate levels of taurine, e.g. lacking in meat,
which is a common occurrence in poor socioeconomic settings
where ETEC infections are common, may further increase the
severity of CS5 ETEC infections. The composition of bile also
varies between different populations, eg. in rural African women
the ratio of glyco- to tauro-conjugated bile acids may be as high as
9:1 [23].
Our results showed that the induction of CS5 is dose-
dependent; a final concentration of sodium glycocholate of
0.004% was not enough to induce phenotypic expression, but a
gradual increase in induction was observed when increasing the
concentration of the salt from 0.04% to 0.4%. Bile is delivered
from the gall bladder into the proximal part of the small intestine
and sequentially decreases in concentration along the intestine due
to re-absorption to the liver. In addition, the bile level is likely to
differ between the intestinal lumen and the mucosal layer. Our
findings suggest that CS5 ETEC bacteria are capable of fine-
tuning the expression of CS5 according to the concentration and
composition of bile, in order for optimal expression to occur at
different sites and under varying nutritional conditions in the
human intestine. CS5 is only expressed in ETEC strains that are
also capable of expressing CS6 [36]. Unlike CS5, however, CS6 is
not dependent on the presence of bile in order to be expressed in
vitro, which suggests that expression of these two important
colonization factors may be induced by different environmental
niches within the host.
Another abundant host factor in the human small intestine,
NaHCO3, was also tested but ruled out as a putative regulator of
CS5. The concentration of NaHCO3 in the intestine is difficult to
measure and exhibits great variability. The concentrations used by
us, 35.7 mM and 71.4 mM, fall within the concentration range
previously reported to positively regulate the virulence factors in
other enteropathogens, i.e. V. cholerae and enterohemorrhagic E.
coli (EHEC). Thus, 35.7 mM NaHCO3 has been found to
upregulate CT and TCP in V. cholerae [19], and 44 mM to induce
the production of virulence factors in EHEC [20].
In summary, we report the novel findings that the ETEC
colonization factor CS5 is considerably more expressed in vivo than
CS6 when co-expressed on the same bacteria and that the bile
component sodium glycocholate, which is abundant in the human
intestine, induces phenotypic expression of CS5 in a dose-
dependent manner.
Materials and Methods
Ethics Statement
This study was conducted according to the principles expressed
in the declaration of Helsinki. The study was approved by the
Research Review Committee and the Ethical Review Committee
of the International Centre for Diarrhoeal Disease Research,
Bangladesh (icddr,b) (protocol# 2001-027). Ethical permission for
the study was also obtained from the Regional Ethical Review
Board, Gothenburg, Sweden (S199-03 and 088-10). Written
informed consent was obtained from study participants prior to
enrollment in the study and the collection of stool and blood
specimens. No children were included in the study.
Collection of in vivo Bacterial Samples from Stools
Watery diarrhoeal stool specimens were collected from adult
patients with acute diarrhoea admitted to the hospital of the
International Centre for Diarrhoeal Disease Research (icddr,b) in
Dhaka, Bangladesh. Fresh stool specimens (10–50 ml) were placed
on ice and brought from the hospital wards to the laboratory
where bacteria present in the stool samples were immediately
isolated essentially as previously described [37] with some
modifications. The stool samples were filtered through sterilized
gauze and centrifuged at 10006g for 10 minutes in order to
remove mucus and other large particles. The supernatant,
containing the bacteria, was carefully removed and centrifuged
at 160006g for 10 minutes. The resulting bacterial pellet, i.e. the in
vivo bacterial sample, was resuspended in 1 ml RNALaterH
(Qiagen, Hilden, Germany), divided into two aliquots of 500 ml,
stored at -70uC and shipped to Sweden for total RNA extraction
and quantification of transcription.
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Isolates
Bacteriological analysis of the stool specimens was performed
essentially as previously described [14]. Specimens were initially
screened for V. cholerae by dark-field microscopy; negative
specimens were further screened for presence of E. coli-like
bacteria, and V. cholerae, Shigella spp, and Salmonella spp by standard
methods [14,38]. Six lactose-fermenting E. coli-like colonies
identified after culture on MacConkey medium were individually
tested for ST and LT by ELISA assays and for the CFs CFA/I,
CS1-8, CS12, CS14, CS17 and CS21 by dot-blot assays
[26,39,40]. DNA from a pool of the six colonies was tested for
the genes encoding LT, STh, and STp by PCR [26,41]. One
representative ETEC colony from each ETEC positive stool
specimen was grown to exponential phase in LB medium and
stored at -70uC in LB supplemented with 20% glycerol; these
strains were further used in the in vitro experiments.
Collection of Blood and Serum Specimens
Blood samples were collected from the patients at the acute
stage of the infection, i.e. on day 2 or 3 of hospitalization, and
during convalescence on days 7 (early convalescence) and 21 (late
convalescence), and stored at -20uC until analyses.
In vitro Culture Conditions
The ETEC isolates were cultured overnight on LB or blood
agar plates at 37uC. Three or six colonies were picked and grown
to exponential phase in LB (pH 7.5) at 37uC with aerated shaking
(150 or 200 rpm) to reach exponential phase. This starting culture
was inoculated into the media to be tested at a final concentration
of 10
7 or 10
8 bacteria/ml, based on the absorbance at OD600, and
cultured overnight at 37uC with shaking (150 rpm). Media tested
were LB, CFA broth [42], and defined minimal medium (M9). M9
medium was supplemented with either glucose (0.2% w/v),
glycerol (0.2% w/v), or casamino acids (1% w/v) as the primary
carbon source. When relevant, crude bile (Oxoid, Hampshire,
UK) was added to a final concentration of 0.15% w/v [26], or
0.015% (in the case of M9). LB medium was supplemented with
Triton X-100 (Sigma, St Louis, MO), sodium bicarbonate (Sigma),
or individual bile salts (Sigma), i.e. sodium cholate hydrate
(NaCH), sodium deoxycholate (NaDC), taurocholic acid sodium
salt hydrate (TCA), sodium chenodeoxycholate (NaCDC), and
sodium glycocholate hydrate (NaGCH), respectively, at different
concentrations as indicated.
Enzyme-linked Immunosorbent Assay (ELISA)
The phenotypic expression of CS5 and CS6 on the bacterial
surface was quantified by inhibition ELISA assays after overnight
culture to stationary phase, essentially as described [43], with a
starting concentration of 10
9 or 10
10 bacteria/ml.
Total RNA Extraction from in vitro Bacterial Cultures
The pellet from one ml of bacterial culture was treated with
lysozyme and RLT buffer (Qiagen) and stored at -70uC. Total
RNA was prepared from a volume corresponding to 10
9 lysed
bacteria with the RNeasy
H Mini Kit (Qiagen, Hilden, Germany),
removing contaminating DNA on-column by using the RNase-
Free DNase Set (Qiagen). Alternatively, approximately 10
9
bacteria were spun down, treated with RNAProtectH (Qiagen)
and stored at -70uC before total RNA extraction. The integrity of
the RNA and absence of contaminating DNA was checked by
agarose gel electrophoresis and the RNA concentration was
measured spectrophotometrically using a NanoDrop
H ND-1000
(NanoDrop Technologies, Wilmington, DE). All RNA samples
were stored at -70uC.
Total RNA Extraction from in vivo Bacterial Samples
In vivo bacterial samples in RNALater were thawed on ice and
spun down at 4uC. The pellet was treated with an appropriate
volume of lysozyme and RLT buffer (Qiagen) before total RNA
extraction using the RNeasyH Mini Kit (Qiagen). Contaminating
DNA was removed by twice performing the on-column DNase
treatment described above.
cDNA Synthesis
cDNA was synthesized from a maximum of 200 ng total RNA
using the QuantiTect Reverse Transcription Kit (Qiagen), which
includes an additional DNAse treatment step. Controls for DNA
contamination without reverse transcriptase (-RT) were prepared
simultaneously with the synthesized cDNA from the same amount
of total RNA. cDNA and (-RT) controls were stored at -20uC.
Quantitative Real Time RT-PCR Assays
The real-time RT-PCR assays were performed on an ABI 7500
(Applied Biosystems, Foster City, CA) using the double-stranded
DNA-specific dye SYBRHGreen I (Applied Biosystems, Warring-
ton, UK) as detector. Primers for the CS5 minor structural subunit
gene csfD and the E. coli housekeeping gene gapA were designed
using the Primer Express 2.0 software (Applied Biosystems, Foster
City, CA). The primers for the CS6 structural subunit gene cssB
have been described previously [44] (Table 2).
The transcription levels were determined by absolute quantifi-
cation using a standard curve for each gene which was generated
by ten-fold serial dilutions of a known amount of specific PCR
product. These PCR products were generated by conventional
PCR from DNA isolated from laboratory strains (E17018/A for
csfD; E11881/14 for cssB and gapA), using the same primers as for
real-time PCR. PCR products were purified by the QIAQuick
PCR Purification Kit (Qiagen) or the E.Z.N.A Cycle Pure Kit
(Omega Bio-Tek, Inc., Norcross, GA), and their concentrations
were carefully determined on a NanoDrop
H ND-1000 (Nano-
Drop). The number of PCR products per ml was calculated as
previously described [37]. The PCR products were then diluted in
Elution Buffer (Qiagen, Omega Bio-Tek) to give ten-fold dilution
series from 5610
7 to 5 PCR products/ml.
Table 2. Primers used for PCR and real-time Reverse
Transcriptase PCR (rt RT-PCR).
Gene Primers (59R39) Direction
Product
size
csfD (CS5)
a ACTTGGATATTGGTCGACTGCAA Forward 101 bp
ATTCTTTAAAACCTCTCCAGCGAAT Reverse
cssB (CS6)
b, c CAGGAACTTCCGGAGTGGTA Forward 152 bp
CTGTGAATCCAGTTTCGGGT Reverse
gapA
d CGTTGAAGTGAAAGACGGTCATC Forward 101 bp
CAACACCAACTTCGTCCCATTT Reverse
aCS5 minor subunit; GenBank accession number AJ224079.
bCS6 structural subunit CssB; GenBank accession number UO4846.
cPrimers described in [44].
dE. coli D-glyceraldehyde-3-phosphate dehydrogenase (GAPDH); GenBank
accession number U014639.1.
doi:10.1371/journal.pone.0035827.t002
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containing 8 pmol of each specific primer, 10 ml Power
SYBRHGreen PCR Master Mix (Applied Biosystems), and
2 ml of template, using the default cycling settings with minor
modifications as described in [45]. Quantification was per-
formed by using the default software settings for the threshold
and baseline values (Applied Biosystems). The number of gene-
specific transcripts per 20 ng of total RNA was calculated.
cDNA samples and corresponding (–RT) controls were run in
parallel. When the difference in Ct values between the sample
and the (–RT) control was $ 3.0 or # 6.6, the number of
transcripts was adjusted accordingly. When the difference was
. 6.6 the (–RT) values were ignored since any contaminating
DNA would account for less than 1% of the total product, but
if the difference was , 3.0 the amount of DNA contamination
was considered too high and the results were discarded. Since
we have previously found a detection limit of 2–3 copies per
reaction for real-time PCR [45] the detection limit in this study
was set at 2 transcripts per reaction, and all results below 2
transcripts were considered as negative.
Measurement of Antibody Response in Serum
Antibody titers of IgG and IgA isotypes against CS5 and CS6
were determined as described previously [25] using purified CS5
(1 mg/ml) and recombinant CS6 (0.3 mg/ml) as coating antigens.
Statistical Analyses
Results were analyzed with the non-parametrical non-paired
Mann-Whitney test using the GraphPad Prism version 4.00 for
Windows (GraphPad Software, San Diego, CA, USA).
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